Opinions Geoff Houlton
Sophiris BioSHS.TOTRADEMar 26, 2008
A drug that corrects complications that occur with the prostrate and prostrate cancer. Entering phase 2 clinical trials, has large market opportunities. Have done safety studies. In good shape regarding their cash position.
Geoff HoultonUnknown
$0.84
Stock price when the opinion was issued
Consumer Products
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
